These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9082630)

  • 1. [Hypertension and left ventricular hypertrophy in patients with spontaneous subarachnoid hemorrhage].
    Toftdahl DB; Torp-Pedersen CT; Engel UH; Strandgaard S; Jepersen B
    Ugeskr Laeger; 1997 Mar; 159(10):1434-7. PubMed ID: 9082630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and left ventricular hypertrophy in patients with spontaneous subarachnoid hemorrhage.
    Toftdahl DB; Torp-Pedersen C; Engel UH; Strandgaard S; Jespersen B
    Neurosurgery; 1995 Aug; 37(2):235-9; discussion 239-40. PubMed ID: 7477774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmias and left ventricular hypertrophy in essential hypertension.
    Palmiero P; Maiello M
    Minerva Cardioangiol; 2000 Dec; 48(12):427-34. PubMed ID: 11253327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmic risk in essential hypertension: late potentials].
    Palmiero P; Maiello M
    Minerva Cardioangiol; 2004 Feb; 52(1):1-8. PubMed ID: 14765032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
    Mondillo S; Agricola E; Ammaturo T; Guerrini F; Barbati R; Focardi M; Picchi A; Ballo P; Nami R
    Can J Cardiol; 2001 May; 17(5):571-7. PubMed ID: 11381279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of ventricular arrhythmia in hypertensive patients].
    Galinier M; Balanescu S; Fourcade J; Dorobantu M; Massabuau P; Dongay B; Cabrol P; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1049-53. PubMed ID: 9404407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elevation of total urinary catecholamines in patients with subarachnoid hemorrhage].
    Rivera Nava C; Corona T; Estañol B; Castrejón E; Abundes Velasco A
    Rev Invest Clin; 1994; 46(3):241-4. PubMed ID: 7973149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.